2019
DOI: 10.4103/ijd.ijd_360_18
|View full text |Cite
|
Sign up to set email alerts
|

Pachydermoperiostosis Associated with Myelofibrosis: A Rare Case Report

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 11 publications
(13 reference statements)
0
2
0
Order By: Relevance
“…In primary hypertrophic osteoarthropathy (pachydermoperiostosis), gene-mutations of the prostaglandin degrading enzyme, 15-hydroxyprostaglandin dehydrogenase (HPGD) and the PG transporter ( SLCO2A1 ) lead to impairment of PGE2 degradation. The resultant increase of PGE 2 levels lead to fibrosis of the marrow [ 37 , 38 ].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In primary hypertrophic osteoarthropathy (pachydermoperiostosis), gene-mutations of the prostaglandin degrading enzyme, 15-hydroxyprostaglandin dehydrogenase (HPGD) and the PG transporter ( SLCO2A1 ) lead to impairment of PGE2 degradation. The resultant increase of PGE 2 levels lead to fibrosis of the marrow [ 37 , 38 ].…”
Section: Introductionmentioning
confidence: 99%
“…T-helper cells having a Th2 immunophenotype tend to promote fibrosis in the tissues where they reside. These cells are characterised by a (CD3 + , CD4 + , CD119 + , CD193 + , Foxo + , CD198 + , CD365 + and IL33α +) immunophenotype and are capable of secreting cytokines (IL-3,4,5,6,10,13,25, and 31) that cause fibrosis [ 32 , 38 , 44 ].…”
Section: Introductionmentioning
confidence: 99%